Alto Neuroscience
ANRO
Alto Neuroscience (ANRO) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $55.00 from $50.00 | Aug 17, 2026 |
| BTIG | Maintained | Buy | $37.00 from $28.00 | Aug 13, 2026 |
| Wedbush | Maintained | Neutral | $26.00 from $24.00 | Aug 13, 2026 |
| Baird | Maintained | Outperform | $36.00 from $38.00 | May 18, 2026 |
| Wedbush | Maintained | Neutral | $24.00 from $21.00 | May 14, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $50.00 | May 11, 2026 |
| Chardan Capital | Maintained | Buy | $30.00 | Apr 22, 2026 |
| Chardan Capital | Maintained | Buy | $30.00 | Apr 2, 2026 |
| Wedbush | Maintained | Neutral | $21.00 from $22.00 | Apr 2, 2026 |
| Jones Trading | Maintained | Buy | $44.00 from $49.00 | Apr 2, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $50.00 | Apr 2, 2026 |
| Baird | Maintained | Outperform | $38.00 from $41.00 | Apr 2, 2026 |
| Baird | Maintained | Outperform | $41.00 from $22.00 | Mar 18, 2026 |
| Wedbush | Maintained | Neutral | $22.00 from $13.00 | Mar 17, 2026 |
| Chardan Capital | Maintained | Buy | $30.00 | Mar 17, 2026 |
| BTIG | Maintained | Buy | $28.00 from $27.00 | Feb 17, 2026 |
| Chardan Capital | Maintained | Buy | $30.00 from $15.00 | Jan 5, 2026 |
| BTIG | Initiated Coverage | Buy | $27.00 | Nov 17, 2025 |
| Baird | Maintained | Outperform | $22.00 from $16.00 | Nov 13, 2025 |
| Jefferies | Maintained | Buy | $25.00 from $15.00 | Nov 12, 2025 |
Frequently asked questions
What is the latest analyst rating on ANRO?
On Aug 17, 2026, HC Wainwright & Co. maintained Alto Neuroscience at Buy with a price target of $55.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.